title: Role of hydroxyethyl starch in ischemia-reperfusion injury in rat intestinal transplantation.
abstract: OBJECTIVE
  This study was designed to evaluate the role of 0%, 3%, 6% hydroxyethyl starch (HES) and University of Wisconsin (UW) perfusion and preservation solutions on ischemia-reperfusion injury (IRI) of rat intestinal transplantations, solutions, respectively.
  
  
  METHODS
  Rats underwent orthotopic intestinal transplantation (Lewis to Lewis) after using perfusion and preservation saline (group l), 3% HES (group 2), 6% HES (group 3), or UW (group 4) solutions. The change in weight was recorded from preoperative to postoperative day (POD) 30. At 30 minutes after reperfusion, we harvested intestinal juice preoperatively as well as at 30 minutes after reperfusion and on POD 1 and 3 when recipients underwent open surgery for maltose absorption tests and sampling. The Park' scores of IRI were evaluated by light microscopy after hematoxylin and eosin (H&E) staining.
  
  
  RESULTS
  An increased weight was more evident in group 2 than the other groups, particularly the on POD 1 and POD 3 (P < .05). It was significantly greater than groups 1 and 3 on POD 7 (P < .05). Compared with the other groups, the 30-minute post-reperfusion. Park score and intestinal juice content in group 2 was decreased significantly (P < .01), while in group 3 the Park score was increased, and the maltose absorption level decreased significantly (P < .05).
  
  
  CONCLUSIONS
  Three percent HES solution attenuated IRI in rat intestinal transplantation. High-concentration HES solutions were unfit for intestinal preservation. Thus the adverse effects of UW solution may be attribute at least in part to its high HES, concentration.
authors: Department of Gastrointestinal Surgery, Second Affiliated Hospital, Harbin Medical University, Harbin, China.
authors: X L
authors: XL
authors: Li
authors: X m
authors: Xm
authors: Zou
authors: G
authors: G
authors: Nie
authors: M L
authors: ML
authors: Song
authors: G
authors: G
authors: Li
authors: W
authors: W
authors: Cui
mesh_terms: D000241:Adenosine / Q000494:pharmacology / Q000633:toxicity; D000493:Allopurinol / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005978:Glutathione / Q000494:pharmacology / Q000633:toxicity; D006085:Graft Survival / Q000187:drug effects; D006895:Hydroxyethyl Starch Derivatives / Q000494:pharmacology* / Q000633:toxicity; D007328:Insulin / Q000494:pharmacology / Q000633:toxicity; D007408:Intestinal Absorption / Q000187:drug effects; D007410:Intestinal Diseases / Q000209:etiology / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D007413:Intestinal Mucosa / Q000378:metabolism; D007419:Intestinal Secretions / Q000378:metabolism; D007422:Intestines / Q000098:blood supply / Q000187:drug effects* / Q000473:pathology / Q000637:transplantation*; D008320:Maltose / Q000378:metabolism; D009926:Organ Preservation / Q000009:adverse effects / Q000379:methods*; D019188:Organ Preservation Solutions / Q000494:pharmacology* / Q000633:toxicity; D009929:Organ Size / Q000187:drug effects; D016377:Organ Transplantation / Q000009:adverse effects; D011887:Raffinose / Q000494:pharmacology / Q000633:toxicity; D051381:Rats; D011917:Rats, Inbred Lew; D015427:Reperfusion Injury / Q000209:etiology / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D013997:Time Factors; D014022:Tissue Survival / Q000187:drug effects
chemical_list: D006895:Hydroxyethyl Starch Derivatives; D007328:Insulin; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; D008320:Maltose; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose